BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,429 | -4.4% | 6,042 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $317,390 | +47.5% | 5,022 | +5.0% | 0.01% | +33.3% |
| Q1 2023 | $215,142 | -3.3% | 4,782 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $222,411 | -26.1% | 4,782 | +4.5% | 0.01% | -30.8% |
| Q3 2022 | $301,000 | +30.3% | 4,576 | 0.0% | 0.01% | +30.0% |
| Q2 2022 | $231,000 | -20.9% | 4,576 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $292,000 | -40.4% | 4,576 | 0.0% | 0.01% | -41.2% |
| Q4 2021 | $490,000 | +4.3% | 4,576 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $470,000 | +15.5% | 4,576 | -1.1% | 0.02% | +13.3% |
| Q2 2021 | $407,000 | -7.1% | 4,626 | +2.8% | 0.02% | -11.8% |
| Q1 2021 | $438,000 | -15.8% | 4,501 | -2.9% | 0.02% | -29.2% |
| Q4 2020 | $520,000 | +17.1% | 4,636 | -3.3% | 0.02% | +20.0% |
| Q3 2020 | $444,000 | +18.7% | 4,793 | 0.0% | 0.02% | +11.1% |
| Q2 2020 | $374,000 | +33.6% | 4,793 | +0.2% | 0.02% | +12.5% |
| Q1 2020 | $280,000 | -18.1% | 4,785 | +12.1% | 0.02% | +6.7% |
| Q4 2019 | $342,000 | +12.1% | 4,267 | +2.6% | 0.02% | +7.1% |
| Q3 2019 | $305,000 | -22.2% | 4,158 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $392,000 | +42.0% | 4,158 | +20.8% | 0.02% | +38.5% |
| Q1 2019 | $276,000 | +48.4% | 3,442 | 0.0% | 0.01% | +30.0% |
| Q4 2018 | $186,000 | -30.9% | 3,442 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $269,000 | +23.4% | 3,442 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $218,000 | -33.7% | 3,442 | -4.2% | 0.01% | -37.5% |
| Q1 2018 | $329,000 | +18.3% | 3,592 | -2.7% | 0.02% | +23.1% |
| Q4 2017 | $278,000 | +51.1% | 3,691 | +8.2% | 0.01% | +44.4% |
| Q3 2017 | $184,000 | +6.4% | 3,410 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $173,000 | +113.6% | 3,410 | +68.9% | 0.01% | +100.0% |
| Q1 2017 | $81,000 | – | 2,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |